EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database

Hyun Kyung Kim, Kyung Sik Jang, Dong Wook Kim

Epilepsy & Behavior · 2024

DOI: 10.1016/j.yebeh.2024.109784 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Epilepsy & Behavior, 2024. Verfasst von Hyun Kyung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Medical Center, Seoul, South Korea. Hauptthemen laut MEDLINE: Anticonvulsants, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Pharmacovigilance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to compare and characterize the safety profiles of new antiseizure medications (ASMs) using a nationwide pharmacovigilance database from a long-term perspective in Korea. METHODS: We reviewed adverse event reports from the Korea Adverse Event Reporting System database between January 2013 and December 2022 for descriptive analysis of six new ASMs (lacosamide, levetiracetam, lamotrigine, oxcarbazepine, topiramate, and zonisamide). We investigated the frequency and characteristics of adverse drug reactions (ADRs) based on the MedDRA terminology, system organ classes, and modified WHO classification. RESULTS: We identified 5,733 reported cases of ADRs. The commonly reported ADRs associated with total ASMs were rash/urticaria (1,822, 31.8 %), dizziness (409, 7.1 %), somnolence/drowsiness (311, 5.4 %), and hepatotoxic effects (273, 4.8 %). Type B (idiosyncratic) effects (2,932; 51.1 %) were more commonly reported than Type A (related to known drug mechanisms) effects (2,613; 45.6 %). Skin and subcutaneous tissue disorders and type B effects were most commonly reported for lamotrigine and oxcarbazepine, whereas nervous system disorders and type A effects were most commonly reported for lacosamide, topiramate, and zonisamide. The pediatric group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsPharmacovigilanceHumansRepublic of KoreaMaleFemaleAdultChildMiddle AgedAdolescentChild, PreschoolYoung AdultAgedInfantTopiramateOxcarbazepineDatabases, FactualLamotrigineLacosamideZonisamideInfant, NewbornLevetiracetam

Stichwörter der Autor:innen

Adverse drug reactionsAntiepileptic drugsAntiseizure medicationsHypersensitivityPharmacovigilance

Substanzen

AnticonvulsantsTopiramateOxcarbazepineLamotrigineLacosamideZonisamideLevetiracetam

Autor:innen und Institutionen

  • Department of Neurology, National Medical Center, Seoul, South Korea.
  • Department of Neurology, Konkuk University School of Medicine, Seoul, South Korea. Electronic address: drdongwkim@kuh.ac.kr.

Zitieren

APA

Kim, H. K., Jang, K. S., & Kim, D. W. (2024). Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2024.109784

Vancouver

Kim HK, Jang KS, Kim DW. Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database. Epilepsy & Behavior. 2024. doi:10.1016/j.yebeh.2024.109784

BibTeX
@article{Kim2024,
  author = {Kim, Hyun Kyung and Jang, Kyung Sik and Kim, Dong Wook},
  title = {Comparative analysis of adverse drug reactions associated with new antiseizure medications from the Korea Adverse Event Reporting System database},
  journal = {Epilepsy & Behavior},
  year = {2024},
  doi = {10.1016/j.yebeh.2024.109784}
}
Kostenlos starten →